Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties

Hyperviscosity syndrome (HVS) recently emerged as a complication of coronavirus disease 2019 (COVID-19) and COVID-19 vaccines. Therefore, the objectives of this critical review are to establish the association between COVID-19 and COVID-19 vaccines with the development of HVS. HVS may develop in var...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-kuraishy, Hayder M., Al-Gareeb, Ali I., El-Bouseary, Maisra M., Sonbol, Fatma I., Batiha, Gaber El-Saber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128329/
https://www.ncbi.nlm.nih.gov/pubmed/35608715
http://dx.doi.org/10.1007/s10238-022-00836-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128329/
https://www.ncbi.nlm.nih.gov/pubmed/35608715
http://dx.doi.org/10.1007/s10238-022-00836-x

Ejemplares similares